Skip to content

ANVS

Annovis Bio, Inc.

NYSE · USHealthcareBiotechnology
$1.69-2.87%

Price as of Jul 20, 2026

ANVS analysis

Annovis Bio, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for ANVS is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research